Max Yates

4.0k total citations
41 papers, 504 citations indexed

About

Max Yates is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Max Yates has authored 41 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Rheumatology and 11 papers in Genetics. Recurrent topics in Max Yates's work include Vasculitis and related conditions (15 papers), Otitis Media and Relapsing Polychondritis (11 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Max Yates is often cited by papers focused on Vasculitis and related conditions (15 papers), Otitis Media and Relapsing Polychondritis (11 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Max Yates collaborates with scholars based in United Kingdom, United States and Australia. Max Yates's co-authors include Richard A. Watts, Alex J. MacGregor, Ann Barrett, Robert Luben, Y. K. Loke, Kay‐Tee Khaw, A. R. Diani, G. C. Gerritsen, Rebecca C. Fitzgerald and Andrew Hart and has published in prestigious journals such as Gastroenterology, Journal of Nutrition and Diabetologia.

In The Last Decade

Max Yates

37 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Yates United Kingdom 11 275 174 102 87 79 41 504
H. Bézanahary France 13 212 0.8× 285 1.6× 75 0.7× 77 0.9× 55 0.7× 42 511
Gary Kunkel United States 10 88 0.3× 318 1.8× 74 0.7× 57 0.7× 68 0.9× 22 552
Shengyun Liu China 15 60 0.2× 264 1.5× 35 0.3× 44 0.5× 52 0.7× 68 560
Carmen Pérez‐Bocanegra Spain 7 245 0.9× 211 1.2× 42 0.4× 38 0.4× 110 1.4× 14 437
Cemal Beş Türkiye 11 84 0.3× 187 1.1× 31 0.3× 63 0.7× 46 0.6× 68 464
Hiroki Yabe Japan 14 144 0.5× 90 0.5× 18 0.2× 110 1.3× 61 0.8× 80 534
Yeonghee Eun South Korea 14 103 0.4× 128 0.7× 18 0.2× 49 0.6× 35 0.4× 40 508
G Rifle France 16 165 0.6× 54 0.3× 60 0.6× 107 1.2× 42 0.5× 70 580
Fernando Ferrando Spain 17 114 0.4× 39 0.2× 99 1.0× 73 0.8× 28 0.4× 35 737
Ralf Knöfler Germany 14 88 0.3× 26 0.1× 108 1.1× 134 1.5× 46 0.6× 69 1.1k

Countries citing papers authored by Max Yates

Since Specialization
Citations

This map shows the geographic impact of Max Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Yates more than expected).

Fields of papers citing papers by Max Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Yates. The network helps show where Max Yates may publish in the future.

Co-authorship network of co-authors of Max Yates

This figure shows the co-authorship network connecting the top 25 collaborators of Max Yates. A scholar is included among the top collaborators of Max Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Yates. Max Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mackie, Sarah, Max Yates, & Kenneth J. Warrington. (2025). Polymyalgia rheumatica and giant cell arteritis: lumping versus splitting. Lara D. Veeken. 65(2).
3.
Welch, Ailsa, et al.. (2025). Are Dietary Patterns Relevant for Reducing the Risk of Fractures and Sarcopenia?. Current Osteoporosis Reports. 23(1). 7–7. 1 indexed citations
4.
Yates, Max, et al.. (2025). YAP1 :: TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma. Molecular Oncology. 20(2). 493–510.
5.
Yates, Max, Charlotte Davies, & Alex J. MacGregor. (2025). Improving polymyalgia rheumatica care: considerations for routine vascular ultrasound in clinical practice. The Lancet Rheumatology. 7(6). e448–e450. 1 indexed citations
6.
Liew, David, Sarah Mackie, Alice Tison, et al.. (2024). Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica. Rheumatic Disease Clinics of North America. 50(2). 255–267. 4 indexed citations
7.
Bösch, Philipp, Louise Falzon, Claire Owen, et al.. (2024). Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review. Lara D. Veeken. 64(2). 455–469. 3 indexed citations
8.
9.
Hum, Ryan Malcolm, Seema Sharma, Michael A. Stadler, et al.. (2023). Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register. Arthritis & Rheumatology. 76(5). 696–703. 6 indexed citations
10.
Engamba, Serge, Emma Henderson, Claire Jones, et al.. (2023). Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice. 8(1). rkae002–rkae002. 2 indexed citations
11.
Owen, Claire, Max Yates, David Liew, et al.. (2023). Imaging of giant cell arteritis – recent advances. Best Practice & Research Clinical Rheumatology. 37(1). 101827–101827. 3 indexed citations
12.
Yates, Max, et al.. (2022). Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?. Current Rheumatology Reports. 24(4). 111–117. 4 indexed citations
13.
Yates, Max, Claire Owen, Sara Müller, et al.. (2020). Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. The Journal of Rheumatology. 47(9). 1379–1384. 7 indexed citations
14.
Owen, Claire, Max Yates, Helen Twohig, et al.. (2019). Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group. The Journal of Rheumatology. 46(10). 1360–1364. 6 indexed citations
15.
Yates, Max & Richard A. Watts. (2017). ANCA-associated vasculitis. Clinical Medicine. 17(1). 60–64. 134 indexed citations
16.
Yates, Max, et al.. (2016). The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population. BMC Musculoskeletal Disorders. 17(1). 285–285. 44 indexed citations
17.
Yates, Max, Edward Cheong, Robert Luben, et al.. (2014). Body Mass Index, Smoking, and Alcohol and Risks of Barrett’s Esophagus and Esophageal Adenocarcinoma: A UK Prospective Cohort Study. Digestive Diseases and Sciences. 59(7). 1552–1559. 40 indexed citations
18.
Yates, Max, Y. K. Loke, Richard A. Watts, & Alex J. MacGregor. (2013). Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. Clinical Rheumatology. 33(2). 227–236. 30 indexed citations
19.
Yates, Max, et al.. (2010). Pyomyositis. Journal of Diabetes and its Complications. 25(5). 346–348. 9 indexed citations
20.
Yates, Max & Ann Barrett. (2009). Oncological Emergency Admissions to the Norfolk and Norwich University Hospital: An Audit of Current Arrangements and Patient Satisfaction. Clinical Oncology. 21(3). 226–233. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026